StockSelector.com
  Research, Select, & Monitor Friday, July 20, 2018 5:54:36 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Endo International plc$11.15($.07)(.62%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Endo International plc vs Drug Delivery

Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.




Innovative companies whose purpose is to design and develop new ways to introduce drugs to the body. These new methods may consist of time-released capsules, differing injection techniques, or enabling certain drugs to be taken orally that may not have been to be taken so before. Their revenue is obtained from selling their technology to pharmaceutical companies or licensing it to manufacturers of prescription drugs.
 Totals Company Industry
  Sales: $3,468.9 Mil $119,413.0 Mil
  Market Cap: $2,507.9 Mil $359,134.5 Mil
  Analysts Recommendation: Buy Buy

 Averages Company Industry
 Growth
  Historic Revenue: (13.5%) 20.0%
  Estimated Revenue: (21.3%) 39.7%
  Historic Earnings: (18.8%) 89.7%
  Estimated Earnings: (16.8%) 14.8%
  Stock Price (1 Year): (7.0%) 53.9%
  Cash per Share: 63.2% (12.0%)
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: 4.4 24.0
  Price-to-Sales: .8 N/A
  Price-to-Book: 5.2 7.2
  Dividend Yield: N/A N/A
  Market Cap: $2,507.9 Mil $27,625.7 Mil
  Operations
  Net Margin: 23.5% (146.6%)
  Gross Margin: 35.8% 73.4%
  Return on Equity: (4.2) (.5)
  Return on Assets: (.2) (.2)
  Balance Sheet
  Current Ratio: 1.0 2.2
  Quick Ratio: .8 1.9
  Cash Ratio: .6 1.4
  Debt-to-Equity: 23.0 3.8
  Interest Coverage: (.1) .5
 Technicals
  Relative-Strength Index: 70.2 N/A

 Other companies in Drug Delivery Price Market Cap
  Roche Holding AG  (RHHBY) $28.91 $197,033.8 Mil
  Sanofi  (SNY) $41.91 $104,624.1 Mil
  Eisai Co Ltd  (ESALY) $99.36 $29,465.7 Mil
  Nektar Therapeutics  (NKTR) $49.08 $7,896.2 Mil
  Alkermes, Inc.  (ALKS) $45.28 $6,992.3 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.